FDA Grants Orphan Drug Designation to TP-1287 for Ewing Sarcoma
The FDA has granted an orphan drug designation to TP-1287, an investigational oral CDK9 inhibitor, for the treatment of patients with Ewing sarcoma.
Sumitomo Dainippon Pharma Jatinj Shah Patricias Andrews Sumitomo Pharma Oncology Inc Sumitomo Pharma Oncology Sumitomo Pharma
Source: onclive.com